{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 7856, "pageSize": 30, "pageCount": 10666, "rows": [ { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "comparison_table", "function": "compare_peers", "notes": "The table uses blue highlighting to emphasize the higher severity metrics in the EBO Ph 2 group.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/10", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "cc73c19c-ae43-4e15-b621-ac27bebabaca", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Phase 2 top-line results and clinical POC", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "LSM = Least squares mean. PRO = Patient-Reported Outcome. The slide highlights alignment with FDA guidance for primary endpoints in NTM trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/11", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "cc73c19c-ae43-4e15-b621-ac27bebabaca", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Phase 2 top-line results and clinical POC", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The chart highlights a statistically significant improvement (p=0.036) at month 6.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/12", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-12", "loopMatches": [ { "to": 13, "from": 12, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "0c6e46af-9fb3-4f7e-900b-28dc0cf96c22", "evidence": "The deck presents clinical response data and QOL-B scores", "position": 1, "objective": "Show clinical response and patient outcomes", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "cc73c19c-ae43-4e15-b621-ac27bebabaca", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Phase 2 top-line results and clinical POC", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart shows a longitudinal comparison of two treatment groups over 6 months. The p-value of 0.043 indicates nominal statistical significance for the difference in mean change from baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/13", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-13", "loopMatches": [ { "to": 13, "from": 12, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "0c6e46af-9fb3-4f7e-900b-28dc0cf96c22", "evidence": "The deck presents clinical response data and QOL-B scores", "position": 1, "objective": "Show clinical response and patient outcomes", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.6, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "cc73c19c-ae43-4e15-b621-ac27bebabaca", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Phase 2 top-line results and clinical POC", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "The slide presents TEAE (Treatment-emergent adverse events) and SAE (Serious adverse events) data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/14", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 9, "beatId": "cc73c19c-ae43-4e15-b621-ac27bebabaca", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Phase 2 top-line results and clinical POC", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "roadmap", "function": "plan_implementation", "notes": "Focuses on PRO (Patient Reported Outcomes) as a primary endpoint for the EBO-301 trial.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/15", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The slide presents three line charts (A, B, C) comparing PBS, IMI (Imipenem), and two doses of EBO (EBO25, EBO50) over 4 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/16", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/17", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a map showing global distribution and a specific callout for US endemicity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/18", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-18", "loopMatches": [ { "to": 21, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "944abad7-bde8-4f0c-bdc1-5248c2eb0f53", "evidence": "The deck presents the high mortality rate of Melioidosis and the need for new treatments", "position": 0, "objective": "Highlight the need for new treatments for Melioidosis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 19, "from": 18, "beatId": "e5b17ee0-de7a-42ad-98ab-a7cbffc359a1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Problem statement for Melioidosis", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a central hub-and-spoke style diagram to connect funding sources with market potential.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/19", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-19", "loopMatches": [ { "to": 21, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "944abad7-bde8-4f0c-bdc1-5248c2eb0f53", "evidence": "The deck presents the high mortality rate of Melioidosis and the need for new treatments", "position": 0, "objective": "Highlight the need for new treatments for Melioidosis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 19, "from": 18, "beatId": "e5b17ee0-de7a-42ad-98ab-a7cbffc359a1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Problem statement for Melioidosis", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "The chart shows Log10 CFU counts in lungs for various treatment groups compared to untreated control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/20", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-20", "loopMatches": [ { "to": 21, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "944abad7-bde8-4f0c-bdc1-5248c2eb0f53", "evidence": "The deck presents the high mortality rate of Melioidosis and the need for new treatments", "position": 0, "objective": "Highlight the need for new treatments for Melioidosis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a dual-track timeline approach to show the progression from observational data collection to clinical trial phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/21", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-21", "loopMatches": [ { "to": 21, "from": 18, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "944abad7-bde8-4f0c-bdc1-5248c2eb0f53", "evidence": "The deck presents the high mortality rate of Melioidosis and the need for new treatments", "position": 0, "objective": "Highlight the need for new treatments for Melioidosis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/22", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "problem_statement", "function": "frame_problem", "notes": "Includes a disease progression timeline diagram on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/23", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a hub-and-spoke diagram to show the global burden relative to specific regions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/24", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a dot map to visualize geographic distribution of infections.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/25", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "Includes chemical structure of the benzoxaborole molecule.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/26", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "traction", "function": "show_traction", "notes": "The chart demonstrates superior efficacy of the lead compound over existing treatments (Benznidazole and E1224) in a model that mirrors human clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/27", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "competitive_analysis", "function": "compare_peers", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/28", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "timeline", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/29", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/30", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to connect Boron to various medical fields, with a specific callout to oncology applications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/31", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to connect the central Boron element to four therapeutic areas, then links to specific development programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/32", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/33", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "b9dcb953-c938-4196-b4d2-25d4a351b161", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Team bios and experience", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/34", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 34, "from": 33, "beatId": "b9dcb953-c938-4196-b4d2-25d4a351b161", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Team bios and experience", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/35", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-72f9-7549-be02-1cb8598bb783", "docSlug": "e2ad68eb257d4e7a3f142ed0c8be9c7f", "documentTitle": "AN2 Therapeutics | Investor Presentation Deck | 36 slides", "authorId": "an2-therapeutics", "authorName": "AN2 Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-72f9-7549-be02-1cb8598bb783/36", "deckHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783", "deckAnchorHref": "/decks/019de077-72f9-7549-be02-1cb8598bb783#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-7395-77e8-a759-85ee5ceb6441", "docSlug": "d10c7e5183f0665a04c27575aa737d7a", "documentTitle": "AstraZeneca | Results Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/j5v07V0x2C59Bg9yiftRCeCNbNIkJc0cJ4jQuQTKcbQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTBjN2U1MTgzZjA2NjVhMDRjMjc1NzVhYTczN2Q3YS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-7395-77e8-a759-85ee5ceb6441/1", "deckHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441", "deckAnchorHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "2cd4eb49-b01a-4c26-9070-0d551d07ea67", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides grab attention with key takeaways and CEO opening remarks.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/a7Ix_4_By8MFSfb5Uhmh5qJJTXTIYGOnPfXnRFKPg4Y/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTBjN2U1MTgzZjA2NjVhMDRjMjc1NzVhYTczN2Q3YS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/_srOL3i4ROic7ByKZ7bo7BGXwXzEdJ63jb1dIycIFAw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTBjN2U1MTgzZjA2NjVhMDRjMjc1NzVhYTczN2Q3YS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/_WVGT7NJzflipwcnkLLyOuHLbvCgVeHeUgnUYq78_4I/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9kMTBjN2U1MTgzZjA2NjVhMDRjMjc1NzVhYTczN2Q3YS9wMDAxLnBuZw" }, { "docId": "019de077-7395-77e8-a759-85ee5ceb6441", "docSlug": "d10c7e5183f0665a04c27575aa737d7a", "documentTitle": "AstraZeneca | Results Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-7395-77e8-a759-85ee5ceb6441/2", "deckHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441", "deckAnchorHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "2cd4eb49-b01a-4c26-9070-0d551d07ea67", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides grab attention with key takeaways and CEO opening remarks.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-7395-77e8-a759-85ee5ceb6441", "docSlug": "d10c7e5183f0665a04c27575aa737d7a", "documentTitle": "AstraZeneca | Results Presentation Deck | 42 slides", "authorId": "astrazeneca", "authorName": "AstraZeneca", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2025-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de077-7395-77e8-a759-85ee5ceb6441/3", "deckHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441", "deckAnchorHref": "/decks/019de077-7395-77e8-a759-85ee5ceb6441#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "2cd4eb49-b01a-4c26-9070-0d551d07ea67", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The opening slides grab attention with key takeaways and CEO opening remarks.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }